Suppresses Appetite: Semaglutide reduces hunger by signaling your brain to feel full, making it easier to manage portion sizes and avoid overeating
It is a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor, which can synergistically regulate appetite, calorie intake, and metabolic function
Its ETA content inhibits both COX and LOX pathways giving it broader anti-inflammatory coverage than standard fish oil alone
Effects on glucose metabolism Increased insulin secretion in a glucose-dependent manner Decreased glucagon secretion Increased insulin sensitivity Possible decrease in blood glucose due to the above-mentioned effects
However, Ozempic is represented to be one of the GLP-1 receptor agonist medicines that was primarily developed to treat type 2 diabetes but has been discussed lately as regards overweight reduction medicines
By reducing appetite, slowing gastric emptying, enhancing insulin secretion, and inhibiting glucagon release, it helps individuals achieve and maintain meaningful weight loss